Mason Freeman

Companies

• CinCor Pharma, Inc.EVP Clinical Development Jan 6, 2022 to Feb 27, 2023¹
• scPharmaceuticals (United States)Board member Jul 24, 2018 to Jun 11, 2020²
• Crinetics PharmaceuticalsBoard member Jul 17, 2018 to Jul 17, 2018³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• CPCinCor Pharma, Inc.0 shares⁴Feb 24, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

• Feb 24, 2023U 100 shares of CinCor Pharma, Inc.⁴
• Feb 24, 2023Returned to company 40,000 shares of CinCor Pharma, Inc.⁴
• Feb 24, 2023U 2,494 shares of CinCor Pharma, Inc.⁴
• Jan 26, 2023Granted 40,000 shares of CinCor Pharma, Inc.⁵
• Jun 10, 2022Sold 6 shares at $15.21 of CinCor Pharma, Inc.⁴
• Jan 11, 2022Bought 100 shares at $16.00 of CinCor Pharma, Inc.⁶
• Jan 11, 2022Bought 2,500 shares at $16.00 of CinCor Pharma, Inc.⁶